公开(公告)号：US20220220082A1

公开(公告)日：2022-07-14

申请号：US17574998

申请日：2022-01-13

Applicant: WiSys Technology Foundation, Inc.

Inventor： Matthew Charles O'Reilly

IPC: C07D239/22 ,  A61P31/04 ,  C07D403/04

Abstract: Emmacin-related substituted dihydropyrimidine compounds demonstrate potency at low concentrations and inhibit Methicillin-resistant S. aureus growth. One such compound is:

公开(公告)号：US12006297B2

公开(公告)日：2024-06-11

申请号：US17574998

申请日：2022-01-13

Applicant: WiSys Technology Foundation, Inc.

Inventor： Matthew Charles O'Reilly

IPC: C07D239/22 ,  A61P31/04 ,  C07D403/04

CPC classification number: C07D239/22 ,  A61P31/04 ,  C07D403/04

Abstract: Emmacin-related substituted dihydropyrimidine compounds demonstrate potency at low concentrations and inhibit Methicillin-resistant S. aureus growth. One such compound is: